Collegium Pharmaceutical (COLL) Earnings Date, Estimates & Call Transcripts → The best inflation-proof investment (From DTI) (Ad) Free COLL Stock Alerts $37.02 -0.49 (-1.31%) (As of 05/6/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateMay. 9After Market ClosesConfirmedActual EPS (Feb. 22) $1.45 Beat By $0.25 Consensus EPS (Feb. 22) $1.20 Get Collegium Pharmaceutical Earnings AlertsEnter your email address below to receive the latest news and earnings results for COLL and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCOLL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.COLL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceYou need to know these two things about AI stocks ASAP…For 40 years, he's been known as one of the world's most bullish investors. Forbes even referred to him a "perma bull"... But he just shocked the world by issuing a massive bear warning about AI stocks.Go here now for this breaking story. Collegium Pharmaceutical Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$1.28$1.28$1.28 Q2 20241$1.24$1.24$1.24 Q3 20241$1.29$1.29$1.29 Q4 20241$1.50$1.50$1.50 FY 20244$5.31$5.31 $5.31COLL Earnings Date and InformationCollegium Pharmaceutical last released its quarterly earnings results on February 22nd, 2024. The specialty pharmaceutical company reported $1.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.20 by $0.25. The business had revenue of $149.75 million for the quarter, compared to analysts' expectations of $147.66 million. Collegium Pharmaceutical has generated $1.18 earnings per share over the last year ($1.18 diluted earnings per share) and currently has a price-to-earnings ratio of 31.4. Earnings for Collegium Pharmaceutical are expected to grow by 10.30% in the coming year, from $5.63 to $6.21 per share. Collegium Pharmaceutical has confirmed that its next quarterly earnings report will be published on Thursday, May 9th, 2024. Collegium Pharmaceutical will be holding an earnings conference call on Thursday, May 9th at 4:30 PM Eastern. Interested parties can register for or listen to the call.. Read More Collegium Pharmaceutical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/9/2024Confirmed)------- 2/22/2024Q4 2023$1.20$1.45+$0.25$2.08$147.66 million$149.75 million11/7/2023Q3 2023$1.11$1.21+$0.10$1.89$139.55 million$136.71 million8/3/2023Q2 2023$1.11$1.13+$0.02$1.92$137.98 million$135.55 million5/4/2023Q1 2023$1.20$1.18($0.02)$2.87$139.11 million$144.77 million2/23/2023Q4 2022$0.88$0.98+$0.10$2.17$127.07 million$129.62 million 11/3/2022Q3 2022$1.04$0.96($0.08)$1.91$123.65 million$127.01 million Get the Latest News and Ratings for COLL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022$1.15($0.04)($1.19)$0.07$122.63 million$123.55 million5/10/2022Q1 2022$0.82$0.42($0.40)$1.23$78.67 million$83.80 million 2/24/2022Q4 2021$0.86($0.73)($1.59)($0.73)$80.75 million$27.36 million11/4/2021Q3 2021$0.75$0.22($0.53)$0.22$84.65 million$78.80 million 8/5/2021Q2 2021$0.34$0.27($0.07)($1.25)$84.29 million$82.94 million Collegium Pharmaceutical Earnings - Frequently Asked Questions When is Collegium Pharmaceutical's earnings date? Collegium Pharmaceutical has confirmed that its next quarterly earnings data will be published on Thursday, May 9th, 2024. Learn more on COLL's earnings history. Did Collegium Pharmaceutical beat their earnings estimates last quarter? In the previous quarter, Collegium Pharmaceutical (NASDAQ:COLL) reported $1.45 earnings per share (EPS) to beat the analysts' consensus estimate of $1.20 by $0.25. Learn more on analysts' earnings estimate vs. COLL's actual earnings. How much revenue does Collegium Pharmaceutical generate each year? Collegium Pharmaceutical (NASDAQ:COLL) has a recorded annual revenue of $566.77 million. How much profit does Collegium Pharmaceutical generate each year? Collegium Pharmaceutical (NASDAQ:COLL) has a recorded net income of $48.15 million. COLL has generated $1.18 earnings per share over the last four quarters. What is Collegium Pharmaceutical's price-to-earnings ratio? Collegium Pharmaceutical (NASDAQ:COLL) has a trailing price-to-earnings ratio of 31.37 and a forward price-to-earnings ratio of 6.58. What is Collegium Pharmaceutical's EPS forecast for next year? Collegium Pharmaceutical's earnings are expected to grow from $5.63 per share to $6.21 per share in the next year, which is a 10.30% increase. More Earnings Resources from MarketBeat Related Companies: IRWD Earnings Date PCRX Earnings Date SYRE Earnings Date BLTE Earnings Date MIRM Earnings Date LGND Earnings Date VRNA Earnings Date XNCR Earnings Date MNKD Earnings Date ABCL Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Apple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings? This page (NASDAQ:COLL) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Collegium Pharmaceutical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
